OWC Pharmaceutical Research
OWC Pharmaceutical Research is a publicly traded (OTCQB: OWCP) Israeli micro-cap that was organized to develop cannabis-based pharmaceuticals through clinical research, but currently shows no active operations, with its website parked and no products, customers, or pipeline disclosed.
- Company typePrivate
- Founded2008
- HeadquartersRamat Gan, Israel
- Headcount11–50
- GTM typeB2B
- OfferingServices
OWC Pharmaceutical Research firmographics
Firmographics- Name
- OWC Pharmaceutical Research
- Website
- https://owcpharma.com
- Company type
- Private
- Founded year
- 2008
- Headcount range
- 11–50 employees
- Short description
- OWC Pharmaceutical Research is a publicly traded (OTCQB: OWCP) Israeli micro-cap that was organized to develop cannabis-based pharmaceuticals through clinical research, but currently shows no active operations, with its website parked and no products, customers, or pipeline disclosed.
- Ownership category
- akta.pro rank
OWC Pharmaceutical Research industry classification
Industry- Product category
- Cannabis Pharmaceutical Research
- NAICS
- Medicinal and Botanical Manufacturing (325411), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD)
- akta.pro secondary industry
- Pain Relief & Anti-Inflammatory (Analgesics) (HLAIADAA)
Keywords
Where OWC Pharmaceutical Research is headquartered
LocationHeadquarters
- HQ city
- Ramat Gan
- HQ country
- Israel
- HQ region
- Middle East
Markets served
OWC Pharmaceutical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations
OWC Pharmaceutical Research product offering
Product offeringCore offering
OWC Pharmaceutical Research conducts medical research and clinical trials aimed at developing cannabis-based pharmaceuticals and treatments. The company engages in pharmaceutical R&D centered on cannabinoid-derived therapeutic candidates, with operations based in Israel.
Differentiator
Problem solved
Functional benefit
Products and services
- Cannabis-based pharmaceutical research and clinical trials
Companies that use OWC Pharmaceutical Research
Customer profileIdeal customer profiles1 record
OWC Pharmaceutical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
OWC Pharmaceutical Research competitors and assessment
Company assessmentDirect peers
- Tetra Bio-Pharma: Canadian clinical-stage pharmaceutical company developing cannabinoid-derived prescription drugs and drug-device combinations. Closely comparable to OWC in target therapeutic applications and small clinical-stage pharmaceutical profile.
- Emerald Health Therapeutics: Canadian life sciences company developing cannabinoid-derived pharmaceutical products. Comparable to OWC as a small public clinical-stage cannabis pharmaceutical developer.
- Corbus Pharmaceuticals: Clinical-stage pharmaceutical company focused on inflammatory and fibrotic diseases, with prior cannabinoid programs. Comparable as a small clinical-stage pharma developing novel mechanism therapies in regulated markets.
- Cannabics Pharmaceuticals: Small U.S./Israel-based pharmaceutical company developing cannabinoid-based precision medicine for cancer and other indications. Closely comparable to OWC as a small clinical-stage cannabis pharma with an Israeli operational footprint.
- Zynerba Pharmaceuticals: Clinical-stage specialty pharmaceutical company developing transdermal cannabinoid therapeutics for neurological and psychiatric conditions. Directly comparable to OWC in terms of size, cannabinoid focus, and clinical-stage pharmaceutical development.
Broad incumbents
- Cronos Group: Global cannabis company with a fermentation-derived cannabinoid pharmaceutical pipeline. Comparable as a broad incumbent with pharmaceutical-grade cannabinoid development programs.
- Canopy Growth: Major cannabis company with pharmaceutical and clinical research arms. Comparable as a broad incumbent pursuing cannabis-based pharmaceutical applications at significant scale.
- Jazz Pharmaceuticals (formerly GW Pharmaceuticals): Acquired GW Pharmaceuticals, the developer of Epidiolex, the first FDA-approved plant-derived cannabinoid prescription medicine. Comparable as the established leader in cannabis-derived prescription pharmaceuticals and the benchmark for OWC's therapeutic category.
- Aurora Cannabis: Canadian licensed producer with a medical cannabis division and pharmaceutical research partnerships. Comparable as a broader incumbent with medical-cannabis pharmaceutical development ambitions.
- Tilray Brands: Global cannabis company with pharmaceutical-grade cannabis production and clinical research operations. Comparable as a large-scale cannabis operator with pharmaceutical ambitions intersecting with OWC's stated focus.
Market position
Customer concentration
OWC Pharmaceutical Research social profiles
Digital presenceOWC Pharmaceutical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
OWC Pharmaceutical Research leadership team
Management profileNumber of profiles
OWC Pharmaceutical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OWC Pharmaceutical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OWC Pharmaceutical Research
What does OWC Pharmaceutical Research do?
OWC Pharmaceutical Research conducts medical research and clinical trials aimed at developing cannabis-based pharmaceuticals and treatments. The company engages in pharmaceutical R&D centered on cannabinoid-derived therapeutic candidates, with operations based in Israel.
When was OWC Pharmaceutical Research founded?
OWC Pharmaceutical Research was founded in 2008. It employs 11 to 50 people.
Where is OWC Pharmaceutical Research based?
OWC Pharmaceutical Research is headquartered in Ramat Gan, Israel, in the Middle East region.
Who are OWC Pharmaceutical Research's main competitors?
Direct peers on record are Tetra Bio-Pharma, Emerald Health Therapeutics, Corbus Pharmaceuticals, Cannabics Pharmaceuticals and Zynerba Pharmaceuticals. Broad incumbents are Cronos Group, Canopy Growth, Jazz Pharmaceuticals (formerly GW Pharmaceuticals), Aurora Cannabis and Tilray Brands.
Does OWC Pharmaceutical Research have an API?
No public API is recorded for OWC Pharmaceutical Research.
What industry is OWC Pharmaceutical Research in?
OWC Pharmaceutical Research's product category is Cannabis Pharmaceutical Research. Its primary akta.pro industry code is HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development), with a secondary code of HLAIADAA, Pain Relief & Anti-Inflammatory (Analgesics). Its NAICS code is 325411 and its SIC code is 2834.